IL17A and psoriasis: Giving a role to the IL-17/IL-23 axis in the pathogenesis of PB, great expectation is placed on the ongoing studies on inhibitors of the IL-17/IL-23 axis in BP, owing also to the great confidence of use derived from their frequent use in psoriasis.